Cargando…
Gephyrin suppresses lung squamous cell carcinoma development by reducing mTOR pathway activation
Background: The mTOR pathway is altered in a multitude of cancers, including lung cancer; however, abnormal activation in this pathway is less common in lung adenocarcinoma (LUAD) than in lung squamous cell carcinoma (LUSC). Gephyrin is a highly conserved and widely expressed ancient protein in vert...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6560210/ https://www.ncbi.nlm.nih.gov/pubmed/31239782 http://dx.doi.org/10.2147/CMAR.S204358 |